Summit Therapeutics plc Skyrocketed
Thu, May 30, 2024 at 07:27 PM
Summit Therapeutics plc (SMMT:NASDAQ) shot up at $10.92, representing a gain of 272.1%. On Thu, May 30, 2024, SMMT:NASDAQ touched a New 2-Week High of $10.92. The stock appeared on our News Catalysts scanner on Thu, May 30, 2024 at 05:37 PM in the 'BIOTECH' category. From Thu, May 16, 2024, the stock recorded 33.33% Up Days and 40.00% Green Days
About Summit Therapeutics plc (SMMT:NASDAQ)
Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies.
Top 10 Gainers:
- Logistic Properties of the Americas (LPA:NYSEMKT), 684.16%
- Summit Therapeutics plc (SMMT:NASDAQ), 272.06%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 84.92%
- F45 Training Holdings Inc. (FXLV:NYSE), 66.67%
- Momentus Inc. (MNTS:NASDAQ), 66.35%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 59.68%
- Smart for Life Inc. (SMFL:NASDAQ), 52.69%
- Phoenix New Media Limited (FENG:NYSE), 38.12%
- Jeffs' Brands Ltd (JFBR:NASDAQ), 35.33%
- OneMedNet Corp. (ONMD:NASDAQ), 33.85%